Allysta Pharmaceuticals Is A Us Based Private Clinical Stage Biopharmaceutical With A Platform Technology Targeting Treatment Of Fibrotic Diseases Offering Broad Applicability Across A Range Of Diseaseswe Are Particularly Focused On Rare Fibrotic Diseases That Qualify For The Advantages Associated With Orphan Drug Designationincluding Rare Conditions Involving The Musclelungliverand Eyeour Lead Drug Candidatealy688Is A First In Class Multi Functional Anti Fibrotic Peptide With Additional Anti Inflammatory And Cell Regenerative Actions Targeting Duchenne Muscular Dystrophya Devastating Genetic Disease Of Young Boys And Is Ready To Enter Human Clinical Trials
